Gene · 2925
Papers2,036
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,036
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [113mIn]In-RM2: a high potential agent for SPECT imaging of GRPR-expressing tumors. | Phys Eng Sci Med | 2025 | 39760843 | PubTator, text mining | PubMed |
| Gastrin-Releasing Peptide Receptor Imaging and Therapy in the Era of Personalized Medicine. | J Nucl Med | 2025 | 39746758 | PubTator, text mining | PubMed |
| Chromosome X-wide common variant association study in autism spectrum disorder. | Am J Hum Genet | 2025 | 39706197 | PubTator, text mining | PubMed |
| Head-to-Head Comparison of [68Ga]Ga-NOTA-RM26 and [18F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective Study. | J Nucl Med | 2025 | 39448271 | PubTator, text mining | PubMed |
| Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers. | Eur Urol | 2025 | 39428326 | PubTator, text mining | PubMed |
| Development of [64Cu]Cu-NODAGA-RGD-BBN as a Novel Radiotracer for Dual Integrin and GRPR-targeted Tumor PET Imaging. | Curr Radiopharm | 2025 | 38409731 | PubTator, text mining | PubMed |
| Gastrin-releasing peptide receptor expression in gastrointestinal stromal tumours. | ESMO Gastrointest Oncol | 2024 | 41646945 | PubTator, text mining | PubMed |
| GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma. | Cells | 2024 | 39768218 | PubTator, text mining | PubMed |
| Deciphering the effects of radiopharmaceutical therapy in the tumor microenvironment of prostate cancer: an in-silico exploration with spatial transcriptomics. | Theranostics | 2024 | 39629134 | PubTator, text mining | PubMed |
| Development of bombesin-tubulysin conjugates using multicomponent chemistry to functionalize both the payload and the homing peptide. | Front Pharmacol | 2024 | 39600359 | PubTator, text mining | PubMed |
| Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study. | Pharmaceutics | 2024 | 39598482 | PubTator, text mining | PubMed |
| Force-transducing molecular ensembles at growing microtubule tips control mitotic spindle size. | Nat Commun | 2024 | 39543105 | PubTator, text mining | PubMed |
| Synthesis and Evaluation of 68Ga- and 177Lu-Labeled [Pro14]bombesin(8-14) Derivatives for Detection and Radioligand Therapy of Gastrin-Releasing Peptide Receptor-Expressing Cancer. | Mol Pharm | 2024 | 39460729 | PubTator, text mining | PubMed |
| PET/CT Assessment of Estrogen Receptor positivity for Breast Cancer using [68Ga]Ga-RM2 Bombesin Receptor Antagonist: A Systematic Review and Meta-Analysis. | Semin Nucl Med | 2024 | 39370376 | PubTator, text mining | PubMed |
| Measurement of absolute abundance of crystallins in human and αA N101D transgenic mouse lenses using 15N-labeled crystallin standards. | Exp Eye Res | 2024 | 39368693 | PubTator, text mining | PubMed |
| Gastrin-releasing peptide receptor as theranostic target in estrogen-receptor positive breast cancer: A preclinical study of the theranostic pair [55Co]Co- and [177Lu]Lu-DOTA-RM26. | Nucl Med Biol | 2024 | 39357076 | PubTator, text mining | PubMed |
| Diagnosis of Prostate Cancer with a Neurotensin-Bombesin Radioligand Combination-First Preclinical Results. | Pharmaceutics | 2024 | 39339259 | PubTator, text mining | PubMed |
| Preclinical Investigation of [212Pb]Pb-DOTAM-GRPR1 for Peptide Receptor Radionuclide Therapy in a Prostate Tumor Model. | J Nucl Med | 2024 | 39327021 | PubTator, text mining | PubMed |
| Kappa opioids inhibit spinal output neurons to suppress itch. | Sci Adv | 2024 | 39321286 | PubTator, text mining | PubMed |
| Detection rate of gastrin-releasing peptide receptor (GRPr) targeted tracers for positron emission tomography (PET) imaging in primary prostate cancer: a systematic review and meta-analysis. | Ann Nucl Med | 2024 | 39287742 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2925/papers?page=6